长链非编码RNA-NEF在肝癌、胃癌、食管癌发生发展中的作用

doi:10.20047/j.issn1673-7210.2023.12.11

Abstract
Figure/Table
References (33)
Related Citation (15)

Download: PDF (430 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Long non-coding RNA (lncRNA) are a class of RNAs＞200 nucleotides in length that do not encode proteins. They regulate gene expression by interacting with RNA and DNA, and their functions are closely related to subcellular localization. In the nucleus, lncRNA regulate gene expression at the epigenetic and transcriptional levels, and in the cytoplasm, it regulate gene expression at the post-transcriptional and translational levels. As a kind of exosome, the abnormal expression of lncRNA has been confirmed to have tumor inhibition or carcinogenic effect, and play an important role in the biological processes of tumor proliferation, apoptosis, immune escape, and so on. LncRNA-NEF is a newly discovered lncRNA in liver cancer, which can inhibit epithelial mesenchymal transformation and metastasis of liver cancer. Follow-up studies have found that lncRNA-NEF plays a role in a variety of tumors, mainly manifested as a cancer suppressor. The incidence of malignant tumor of digestive system is high, the prognosis is poor and the survival time is short. In this paper, the main characteristics of lncRNA-NEF and the progress of its role in liver cancer, gastric cancer, and esophageal cancer were reviewed, in order to provide a basis for the discovery of new tumor diagnostic markers and prognostic indicators, and provide new ideas for its treatment and explore new targets for tumor treatment.

Key words： Long non-coding RNA-NEF Liver cancer Gastric cancer Esophageal cancer Biomarker

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	JIA Ganggang LI Bin LU Lixia YU Xiaohui

Cite this article:

JIA Ganggang LI Bin LU Lixia YU Xiaohui. Role of long non-coding RNA-NEF in the genesis and development of hepatocellular carcinoma, gastric carcinoma, and esophageal carcinoma[J]. 中国医药导报, 2023, 20(12): 52-54.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.12.11 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I12/52

[1] Kopp F，Mendell JT. Functional Classification and Experimental Dissection of Long Noncoding RNAs [J]. Cell，2018， 172（3）：393-407.
[2] Esteller M. Non-coding RNAs in human disease [J]. Nat Rev Genet，2011，12（12）：861-874.
[3] Glassman ML，de Groot N，Hochberg A. Relaxation of imprinting in carcinogenesis [J]. Cancer Genet Cytogenet，1996， 89（1）：69-73.
[4] Tragante V，Moore JH，Asselbergs FW. The ENCODE project and perspectives on pathways [J]. Genet Epidemiol，2014， 38（4）：275-280.
[5] Huang JZ，Chen M，Chen D，et al. A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth [J]. Mol Cell，2017，68（1）：171-184.
[6] Sun L，Wang W，Han C，et al. The oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation [J]. Mol Cell，2021，81（21）：4493-4508.
[7] Peng WX，Koirala P，Mo YY. LncRNA-mediated regulation of cell signaling in cancer [J]. Oncogene，2017，36（41）：5661- 5667.
[8] Tan YT，Lin JF，Li T，et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer [J]. Cancer Commun（Lond），2021，41（2）：109-120.
[9] Esposito R，Bosch N，Lanzos A，et al. Hacking the Cancer Genome：Profiling Therapeutically Actionable Long Non- coding RNAs Using CRISPR-Cas9 Screening [J]. Cancer Cell，2019，35（4）：545-557.
[10] Villanueva A. Hepatocellular Carcinoma [J]. N Engl J Med，2019，380（15）：1450-1462.
[11] El-Serag HB，Marrero JA，Rudolph L，et al. Diagnosis and treatment of hepatocellular carcinoma [J]. Gastroenterology，2008，134（6）：1752-1763.
[12] Pang Y，Liu Z，Han H，et al. Peptide SMIM30 promotes HCC development by inducing SRC/YES1 membrane anchoring and MAPK pathway activation [J]. J Hepatol，2020，73（5）：1155-1169.
[13] Li W，Xu W，Song JS，et al. LncRNA SNHG16 promotes cell proliferation through miR-302a-3p/FGF19 axis in hepatocellular carcinoma [J]. Neoplasma，2019，66（3）：397- 404.
[14] Tang C，Feng W，Bao Y，et al. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase（TCPTP）[J]. Bioengineered，2021，12（1）：2119-2131.
[15] Zhu HR，Yu XN，Zhang GC，et al. Comprehensive analysis of long noncoding RNAmessenger RNAmicroRNA coexpression network identifies cell cyclerelated lncRNA in hepatocellular carcinoma [J]. Int J Mol Med，2019，44（5）：1844-1854.
[16] Liang WC，Ren JL，Wong CW，et al. LncRNA-NEF antagonized epithelial to mesenchymal transition and cancer metastasis via cis-regulating FOXA2 and inactivating Wnt/beta-catenin signaling [J]. Oncogene，2018，37（11）：1445-1456.
[17] Wang B，Liu G，Ding L，et al. FOXA2 promotes the proliferation，migration and invasion，and epithelial mesenchymal transition in colon cancer [J]. Exp Ther Med，2018，16（1）：133-140.
[18] Li H，Lan T，Liu H，et al. IL-6-induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinoma [J]. Hepatology，2022，75（6）：1402-1419.
[19] Liang Z，Zhu B，Meng D，et al. Down-regulation of lncRNA-NEF indicates poor prognosis in intrahepatic cholangiocarcinoma [J]. Biosci Rep，2019，39（5）：BSR20181573.
[20] Luo Y，Zheng S，Wu Q，et al. Long noncoding RNA（lncRNA）EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation [J]. Autophagy，2021，17（12）：4083- 4101.
[21] Zhang J，Guo S，Piao HY，et al. ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1 [J]. J Physiol Biochem，2019， 75（3）：379-389.
[22] Zhang L，Kang W，Lu X，et al. LncRNA CASC11 promoted gastric cancer cell proliferation，migration and invasion in vitro by regulating cell cycle pathway [J]. Cell Cycle，2018， 17（15）：1886-1900.
[23] Wu H，Liu B，Chen Z，et al. MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/ PGC1alpha/CEBPB axis to promote stemness and chemo- resistance of gastric cancer [J]. Cell Death Dis，2020，11（4）：233.
[24] Xi Z，Si J，Nan J. LncRNA MALAT1 potentiates autopha- gyassociated cisplatin resistance by regulating the microRNA30b/autophagyrelated gene 5 axis in gastric cancer [J]. Int J Oncol，2019，54（1）：239-248.
[25] Wang X，Jiang X，Zhou L，et al. LncRNANEF is involved the regulation of gastric carcinoma cell proliferation by targeting RUNX1 [J]. Mol Med Rep，2019，19（3）：2051-2056.
[26] Bray F，Ferlay J，Soerjomataram I，et al. Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin，2018，68（6）：394-424.
[27] Hirata H，Niida A，Kakiuchi N，et al. The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy[J]. Cancer Res，2021，81（19）：4926-4938.
[28] Liang M，Liu Y，Zhang Z，et al. Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells，leading to cisplatin resistance [J]. Ann Med，2022，54（1）：989-1003.
[29] Li W，Zhang L，Guo B，et al. Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma [J]. Mol Cancer，2019，18（1）：22.
[30] Sun Y，Wang J，Ma Y，et al. Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR- 199a1 processing and the exosomal transfer of miR-199a- 5p [J]. J Exp Clin Cancer Res，2021，40（1）：306.
[31] 刘旭初，覃世运，陈丽君，等.食管鳞癌组织中LncRNA SNHG7的表达水平及与患者预后的关系[J].现代肿瘤医学，2020，28（13）：2259-2263.
[32] Ren P，Zhang H，Chang L，et al. LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT [J]. Eur Rev Med Pharmacol Sci，2020，24（7）：3686-3693.
[33] Zhang J，Hu S L，Qiao CH，et al. LncRNA-NEF inhibits proliferation，migration and invasion of esophageal squamous-cell carcinoma cells by inactivating wnt/beta-catenin pathway [J]. Eur Rev Med Pharmacol Sci，2018，22（20）：6824-6831.